ADIPOQ and metabolic syndrome: This result suggests a potential role of adiponectin in the pathogenesis and maintenance of OSAS; such decreased adiponectin levels might also explain the high incidence of cardiovascular issues and the metabolic syndrome among individuals with OSAS. Future studies, of course, can be performed with an emphasis on geographical area, race, and severity of OSAS or AHI to further determine the effect of these interfering factors.